Global Cardiovascular Stent Market - Forecasts from 2018 to 2023
The global cardiovascular stent market was valued at US$8.46 billion in 2017 and is projected to expand at a CAGR of 6.74% over the forecast period to reach US$12.511 billion by 2023. A cardiovascular stent is a device in the form of a tube mesh which expands when placed in the coronary artery (which supplies blood to the heart). The stent is required to clear the arterial passage for a smooth blood flow, which would otherwise cause heart attack in case of diseased conditions such as a blockage in the artery. The increase in the adult population along with the growing cardiovascular diseases is leasing to the growth of the global cardiovascular stent market.
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the cardiovascular stent value chain. Last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global cardiovascular stent market.
Major industry players profiled as part of the report are Boston Scientific Corporation, Medtronic, Inc., and Abbot Laboratories among others.
Segmentation
The global cardiovascular stent market has been analyzed through following segments:
By Type
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the cardiovascular stent value chain. Last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global cardiovascular stent market.
Major industry players profiled as part of the report are Boston Scientific Corporation, Medtronic, Inc., and Abbot Laboratories among others.
Segmentation
The global cardiovascular stent market has been analyzed through following segments:
By Type
- Dual Therapy Stent
- Bioresorbable Vascular Scaffold
- Bio-engineering Stent
- Drug Eluting Stent
- Bare Metal Stent
- Stainless Steel
- Cobalt Chromium
- Nitinol
- Polymers
- Hospitals
- Ambulatory Surgical Centers
- Research Institutes
- North America
- South America
- Europe
- Middle East and Africa
- Asia Pacific
1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Force Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. GLOBAL CARDIOVASCULAR STENT MARKET BY TECHNOLOGY
5.1. Dual therapy Stent
5.2. Bioresorbable Vascular Scaffold
5.3. Bio-engineered Stent
5.4. Drug Eluting Stent
5.5. Bare Metal Stent
6. GLOBAL CARDIOVASCULAR STENT MARKET BY MATERIAL
6.1. Stainless Steel
6.2. Cobalt Chromium
6.3. Nitinol
6.4. Polymers
7. GLOBAL CARDIOVASCULAR STENT MARKET BY END USER
7.1. Hospitals
7.2. Ambulatory Research Centeres
7.3. Research Institutes
8. GLOBAL CARDIOVASCULAR STENT MARKET BY GEOGRAPHY
8.1. North America
8.2. South America
8.3. Europe
8.4. Middle East and Africa
8.5. Asia Pacific
9. COMPETITIVE INTELLIGENCE
9.1. Market Share Analysis
9.2. Recent Deals and Investment
9.3. Strategies of Key Players
10. COMPANY PROFILES
10.1. Abbot Laboratories
10.1.1. Company Overview
10.1.2. Financials
10.1.3. Products and Services
10.1.4. Recent Developments
10.2. Medtronic, Inc.
10.2.1. Company Overview
10.2.2. Financials
10.2.3. Products and Services
10.2.4. Recent Developments
10.3. Boston Scientific Corporation
10.3.1. Company Overview
10.3.2. Financials
10.3.3. Products and Services
10.3.4. Recent Developments
10.4. Bioabsorbable Therapeutics, Inc.
10.4.1. Company Overview
10.4.2. Financials
10.4.3. Products and Services
10.4.4. Recent Developments
10.5. Arterial Remodelling Technologies
10.5.1. Company Overview
10.5.2. Financials
10.5.3. Products and Services
10.5.4. Recent Developments
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Force Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. GLOBAL CARDIOVASCULAR STENT MARKET BY TECHNOLOGY
5.1. Dual therapy Stent
5.2. Bioresorbable Vascular Scaffold
5.3. Bio-engineered Stent
5.4. Drug Eluting Stent
5.5. Bare Metal Stent
6. GLOBAL CARDIOVASCULAR STENT MARKET BY MATERIAL
6.1. Stainless Steel
6.2. Cobalt Chromium
6.3. Nitinol
6.4. Polymers
7. GLOBAL CARDIOVASCULAR STENT MARKET BY END USER
7.1. Hospitals
7.2. Ambulatory Research Centeres
7.3. Research Institutes
8. GLOBAL CARDIOVASCULAR STENT MARKET BY GEOGRAPHY
8.1. North America
8.2. South America
8.3. Europe
8.4. Middle East and Africa
8.5. Asia Pacific
9. COMPETITIVE INTELLIGENCE
9.1. Market Share Analysis
9.2. Recent Deals and Investment
9.3. Strategies of Key Players
10. COMPANY PROFILES
10.1. Abbot Laboratories
10.1.1. Company Overview
10.1.2. Financials
10.1.3. Products and Services
10.1.4. Recent Developments
10.2. Medtronic, Inc.
10.2.1. Company Overview
10.2.2. Financials
10.2.3. Products and Services
10.2.4. Recent Developments
10.3. Boston Scientific Corporation
10.3.1. Company Overview
10.3.2. Financials
10.3.3. Products and Services
10.3.4. Recent Developments
10.4. Bioabsorbable Therapeutics, Inc.
10.4.1. Company Overview
10.4.2. Financials
10.4.3. Products and Services
10.4.4. Recent Developments
10.5. Arterial Remodelling Technologies
10.5.1. Company Overview
10.5.2. Financials
10.5.3. Products and Services
10.5.4. Recent Developments
